340B State Legislation: Week of April 5

Senate and House committees are beginning to close as the legislative session nears conclusion but two bills to prohibit discriminatory reimbursement in the 340B program continue to make progress. Read on to learn more about the status of the legislation.
What is the status of the discriminatory reimbursement legislation? 

Two bills in the Tennessee General Assembly to prohibit discriminatory reimbursement in the 340B drug pricing program are moving through the legislative process.  
SB1205/HB1348, sponsored by Senator Briggs and Representative Helton, will prohibit Pharmacy Benefit Managers (PBMs) and other third parties from engaging in discriminatory reimbursement. 

On Monday, March 29, HB1348 passed the full House on an 89-0 vote.  

On March 30, SB1205 passed the Senate Commerce & Labor Committee and was sent to the Senate Calendar Committee.
SB1617/HB1398, sponsored by Senator Reeves and Representative Helton, contains the language of SB1205/HB1348, along with additional provisions related to PBMs.  

On Tuesday, April 6, HB1398 passed the House Insurance Committee and was referred to the House Finance, Ways, and Means Subcommittee.  

SB1617 passed the Senate Commerce & Labor Committee on March 23 and will be considered by the Senate Finance Committee.  
You can stay up-to-date on the Tennessee General Assembly calendars and tune in live to the committee hearings by visiting the Tennessee General Assembly website. 

Review Schedules and Calendars >>> 



Upcoming Events

View All Events